Natalie Tigue

Natalie Tigue is a Principal Scientist at AstraZeneca, where they lead technology landscaping efforts to engineer intelligent cell therapy products. Prior to this, Natalie held roles at MedImmune as a Senior Scientist in Antibody Development and Protein Engineering, and at GlaxoSmithKline as an Investigator specializing in gene cloning and proteomics. They completed their PhD in Biochemistry and Molecular Biology at Cardiff University after obtaining a BSc Hons in Biochemistry from the same institution. Natalie's extensive experience includes significant advancements in therapeutic developments and mentoring start-up companies.